Quantcast

Latest cell therapy Stories

2014-10-14 08:30:39

HypoThermosol® and CryoStor® Embedded in Internal Cell Therapy Candidates and Numerous Mutual Customer Regenerative Medicine Applications BOTHELL, Wash., Oct. 14, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"), today provided an update on use of the...

2014-10-13 08:27:37

DUBLIN, Oct. 13, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Regenerative Medicines Market (Technology, Application and Geography) - Size, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs,...

2014-10-09 08:28:44

NSI-566 to be Tested in Four Patients with Chronic Spinal Cord Injury GERMANTOWN, Md., Oct. 9, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the first patient was treated last week in the Phase I trial testing NSI-566 human neural stem cells in the treatment of chronic spinal cord injury (cSCI) at the UC San Diego School of Medicine. The patient has been discharged from the hospital. The NSI-566/cSCI Phase I trial will treat four patients who have thoracic spinal...

2014-10-07 08:29:00

NEW YORK and PETACH TIKVAH, Israel, Oct. 7, 2014 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the United States Food and Drug Administration (FDA) has designated NurOwn(TM) as a Fast Track product for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease). NurOwn(TM) consists of autologous mesenchymal stem cells that have been induced to...

2014-10-06 08:29:21

SAN DIEGO, Oct. 6, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company developing a stem cell-derived islet replacement therapy for the treatment of diabetes, called VC-01(TM), will give two presentations at the annual Stem Cell Meeting on the Mesa Conference, being held at the Estancia La Jolla Hotel & Spa and The Salk Institute for Biological Studies, as follows: -- Dr. Paul Laikind, ViaCyte's President and Chief Executive Officer, is...

2014-10-02 23:07:16

Dr. Todd Malan addresses the use of adult stem cells and their efficacy in treatment at the 14th Annual Scientific Educational Conference covering healthcare in the Bahamas. Freeport, Grand Bahama (PRWEB) October 02, 2014 Dr. Todd K. Malan, M.D., presented to the Grand Bahama Medical & Dental Association 14th Annual Scientific Educational Conference on the science, safety and efficacy of adipose- (fat) derived stem and regenerative cells (ADRCs) for ischemic heart disease and other...

2014-10-01 12:31:43

CINCINNATI, Oct. 1, 2014 /PRNewswire-USNewswire/ -- Researchers developed a new type of cell transplantation to treat mice mimicking a rare lung disease that one day could be used to treat this and other human lung diseases caused by dysfunctional immune cells. http://photos.prnewswire.com/prnvar/20110406/MM79025LOGO Scientists at Cincinnati Children's Hospital Medical Center report their findings in a study posted online Oct. 1 by Nature. In the study, the authors used macrophages,...

2014-09-30 23:22:37

In a recent online interview by the Pharma IQ Division of the International Quality & Productivity Center (IQPC), James L. Sherley, M.D., Ph.D., the Director of the Adult Stem Cell Technology Center, LLC (ASCTC) discussed the state of technology for drug evaluations for stem cell toxicity. As an expert on the topic, Dr. Sherley emphasized that, currently, few technologies exist for screening-out drug candidates that will ultimately fail as medicines due to toxicity against stem cells...

2014-09-30 16:27:57

Hospital Awarded Accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT) ZION, Ill., Sept. 30, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA(®)) at Midwestern Regional Medical Center (Midwestern) has been recognized by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product...

2014-09-30 12:29:55

ORLANDO, Fla., Sept. 30, 2014 /PRNewswire/ -- CORD:USE Cord Blood Bank - www.corduse.com - is pleased to announce that it has entered into an Equity and Exclusive Services Agreement with Tianhe Stem Cell Biotechnologies, Inc. (Tianhe) which has licensed a series of patented technologies for the isolation of human cord blood-derived multipotent stem cells for possible clinical applications. Tianhe is performing Phase I/II clinical trials in China and Spain using Tianhe's Stem Cell...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.